Our intention is to manufacture and sell HZB Pharma branded, standardized phytocannabinoid-based formulated medicinal products in formats that are most suitable to these targeted patients, namely:
- Broad spectrum cannabinoid distillate (CBD, CBDA, THC, THCA as well as others)
- CBD isolates (crystalline powder form)
- THCA isolates (crystalline powder form)
- Minor cannabinoid isolation
- Topical applications (creams, balms, salves, etc.)
Multiple format and dosage offerings will be commercialized sequentially. Medicinal products will be available to Canadians via provincial stores such as SQDC or direct to patients with prescriptions.